Julphar (Gulf Pharmaceutical Industries)

Julphar Gulf Pharmaceutical Industries manufactures general medicines, injections, vaccines, and consumer healthcare products. Its portfolio addresses therapeutic areas including diabetes, gastrointestinal conditions, respiratory care, pain management, wound and scar care, anti-infectives, anemia, gynecology, dermatology, erectile dysfunction, and cardiology. The company also produces insulin and vitamin supplements. Its general medicines are products whose patents have typically expired and are manufactured to the same standards as original medicines. Products serve retail pharmacy channels and hospitals, supporting treatments for conditions ranging from headaches to heart disease.

Established in 1980 under the guidance of Sheikh Saqr Bin Mohammed Al Qasimi, the late ruler of Ras Al Khaimah, the company operates across the Middle East and Africa. It is one of the region's largest diabetes drug producers and the only insulin manufacturer in the United Arab Emirates. Around 3,000 employees support a manufacturing network of 10 internationally accredited facilities with capacity to produce up to one million medicine boxes per day. Manufacturing processes are validated, equipment is tested and certified, and supplier procedures are supervised. High-volume distribution facilities support delivery of new products to more than 40 countries across five continents.